Reactive oxygen species and matrix remodeling in diabetic kidney

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 3, 2003, Pages

  Ha, Hunjoo ^a   Lee, Hi Bahl ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ALPHA ACTIN; ANGIOTENSIN; ANTIOXIDANT; BUTHIONINE SULFOXIMINE; CATALASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; GELATINASE B; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; SMAD2 PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; TROLOX C; UROKINASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLOMERULUS; HUMAN; HUMAN CELL; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY TUBULE EPITHELIUM; MESANGIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0042366348     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Steffes MW, Osterby R, Chavers B, Mauer M: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1984
2. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999
3. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
4. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001
5. Yang J, Shultz RW, Mars WM, Rodney E, Wegner RE, Li Y, Dai C, Nejak K, Liu Y: Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538, 2002
6. Lan HY: Tubular epithelial-myofibroblast transdifferentiation mechanism in proximal tubule cells. Curr Opin Nephrol Hypertens 12: 25-29, 2003
7. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
8. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells. Am J Physiol 278: F676-F683, 2000
9. Yamagishi S-I, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M: Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells. Kidney Int 63: 464-473, 2003
10. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998
11. Yang Y, Ha H, Lee HB: Role of reactive oxygen species in TGF-β1-induced epithelial-mesenchymal transition [Abstract]. Nephrol Dial Transplant 18[Suppl 4]: 300, 2003
12. Ha H, Lee HB: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58[Suppl 77]: S19-S25, 2000
13. Mignatti P: Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int 47[Suppl 49]: S12-S14, 1995
14. Schnaper HW: Balance between matrix synthesis and degradation: A determinant of glomerulosclerosis. Pediatr Nephrol 9: 104-111, 1995
15. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148: 1345-1350, 1996
16. Wong AP, Cortez SL, Baricos WH: Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells. Am J Physiol 263: F1112-F1118, 1992
17. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636, 1981
18. Mochan E, Keler T: Plasmin degradation of cartilage proteoglycan. Biochim Biophys Acta 800: 312-315, 1984
19. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP: Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50: 5997-6001, 1990
20. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 86: 2632-2636, 1989
21. Nagase H, Enghild JJ, Suzuki K, Salvesen G: Stepwise activation mechanism of the precursor of matrix metalloproteinase 3 (stromolysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 29: 5783-5789, 1990
22. Baricos WH, Cortes SL, El-Dahar SS, Schnaper W. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47: 1039-1047, 1995
23. Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP: Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58: 1841-1850, 2000
24. Lee HB, Seo J, Jiang Z, Ha H: Reactive oxygen species mediate high glucose- and TGF-β-induced upregulation of plasminogen activator inhibitor-1 expression in mesangial cells [Abstract]. European Diabetic Nephropathy Study Group 15th Meeting, Barcelona-Catalunya, Spain, May 2-4, 2002
25. Baricos WH, Cortez SL, Deboisblanc M, Xin S: Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 10: 790-795, 1999
26. Tamooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42: 1462-1469, 1992
27. Kanalas JJ, Hopfer U: Effect of TGF-β1 and TNF-α on the plasminogen system of rat proximal tubular epithelial cells. JAm Soc Nephrol 8: 184-192, 1997
28. McLennan SV, Fisher E, Martell SY, Death AK, Williams PF, Lyons JG, Yue DK: Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: Possible role in diabetic nephropathy. Kidney Int 58[Suppl 77]: S81-S87, 2000
29. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Spl glycosylation. Proc Natl Acad Sci U S A 97: 12222-12226, 2000
30. Cheng JJ, Chao YJ, Wung BS, Wang DL: Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species. Biochem Biophys Res Commun 225: 100-105, 1996
31. Zhao W, Spitz DR, Oberley LW, Robbins ME: Redox modulation of the pro-fibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res 61: 5537-5543, 2001
32. Li JH, Zhu HJ, Huang XR: Smad7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking smad2 activation. J Am Soc Nephrol 13: 1464-1472, 2002
33. Oldfield MD, Bach LS, Forbes JM, Nikolic-Pateerson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001
34. Hunag XR, Li JH, Chen YX, Johnson RJ, Lan HY: SMAD signaling, a novel pathway of angiotensin II-induced renal fibrosis [Abstract]. J Am Soc Nephrol 12: 465A, 2001
35. 2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 163: 152-157, 2001
36. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL: p38 mitogen-activated protein kinase is required for TGF-β-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115: 3193-3206, 2002
37. Yang J-Q, Zhao W, Duan H, Robbins MEC, Buettner GR, Oberley LW, Domann FE: v-Ha-Ras oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-κB. Free Radic Biol Med 31: 520-529, 2001